Lixte Biotechnology
LIXT
LIXT
17 hedge funds and large institutions have $2.97M invested in Lixte Biotechnology in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.48% more ownership
Funds ownership: 9.62% → 10.1% (+0.48%)
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.12M | |
| 2 | +$184K | |
| 3 | +$149K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$114K |
| 5 |
Two Sigma Investments
New York
|
+$65.6K |
Top Sellers
| 1 | -$500K | |
| 2 | -$69.2K | |
| 3 | -$16.7K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.27K |
| 5 |
CS
Clear Street
New York
|
-$503 |
